Luteinizing hormone-releasing hormone (LHRH) analogue: clinical trials recruiting now
3
Recruiting trials
3
Conditions studied
1
US states with sites
1
Countries
Phase breakdown
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Prostate Cancer · Luteinizing hormone-releasing hormone (LHRH) analogue for Prostate Cancer | 3 |
| Metastatic Castration-resistant Prostate Cancer | 2 |
| Bipolar disorder | 1 |
Recruiting trials involving Luteinizing hormone-releasing hormone (LHRH) analogue
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
- The COSMYC Trial (COmbined Suppression of MYC)
Common questions
How many recruiting trials involve Luteinizing hormone-releasing hormone (LHRH) analogue?
3 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.